Clinical Trial Update: The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain [NA]

View source ↗

Summary

A completed clinical trial evaluated whether loteprednol reduces post-intravitreal injection pain in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lotemax (Loteprednol etabonate)

Snippet

Sponsor: Virginia Polytechnic Institute and State University | Conditions: Age-Related Macular Degeneration | NA | Status: COMPLETED